Table 7.
Time in Hospital and Nonhematologic Grade 3 and 4 Toxicities Related to Lymphodepleting Chemotherapy and Cell Transfer
| Patients |
||
|---|---|---|
| Characteristic | No. | % |
| Days in hospital* | ||
| 6-10 | 6 | 17 |
| 11-15 | 18 | 51 |
| 16-20 | 4 | 11 |
| 21-25 | 7 | 20 |
| pRBC transfusions | ||
| 0 | 2 | 6 |
| 1-5 | 18 | 51 |
| 6-10 | 13 | 37 |
| 11-15 | 2 | 6 |
| Platelet transfusions | ||
| 0 | 6 | 17 |
| 1-5 | 21 | 60 |
| 6-10 | 5 | 14 |
| 11-15 | 2 | 6 |
| 16-20 | 1 | 3 |
| Autoimmunity | ||
| Uveitis | 5 | 14 |
| Vitiligo | 13 | 37 |
| Opportunistic infections | ||
| Herpes zoster | 3 | 9 |
| Pneumocystis pneumonia | 2 | 6 |
| EBV-B-cell lymphoma | 1 | 3 |
| RSV pneumonia | 1 | 3 |
| Other | ||
| Febrile neutropenia | 13 | 37 |
| Intubated for dyspnea | 3 | 9 |
| Cortical blindness | 1 | 3 |
Abbreviations: pRBC, peripheral red blood cells; EBV, Epstein-Barr virus; RSV, respiratory syncytial virus.
*
Measured from the day of cell administration to discharge.